These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6876030)

  • 21. Expressions of scavenger receptor, CD14 and protective mechanisms of carboxymethyl-beta-1, 3-glucan in posttraumatic endotoxemia in mice.
    Yang C; Gao J; Dong H; Zhu PF; Wang ZG; Jiang JX
    J Trauma; 2008 Dec; 65(6):1471-7. PubMed ID: 19077645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucan phosphate potentiates endotoxin-induced interferon-gamma expression in immunocompetent mice, but attenuates induction of endotoxin tolerance.
    Sherwood ER; Varma TK; Fram RY; Lin CY; Koutrouvelis AP; Toliver-Kinsky TE
    Clin Sci (Lond); 2001 Dec; 101(6):541-50. PubMed ID: 11724637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial infection modulated by glucan: a search for the host defense potentiation mechanisms.
    Franĕk J; Malina J; Krátká H
    Folia Microbiol (Praha); 1992; 37(2):146-52. PubMed ID: 1505872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of antiserum and phagocytic cells in the protection of mice against infection by Klebsiella pneumoniae.
    Fukutome T; Mitsuyama M; Takeya K; Nomoto K
    J Gen Microbiol; 1980 Jul; 119(1):225-9. PubMed ID: 6997433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promotion of wound healing by yeast glucan evaluated on single animals.
    Wolk M; Danon D
    Med Biol; 1985; 63(2):73-80. PubMed ID: 3840858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary alveolar macrophage. Defender against bacterial infection of the lung.
    Goldstein E; Lippert W; Warshauer D
    J Clin Invest; 1974 Sep; 54(3):519-28. PubMed ID: 4853956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of experimental peritonitis in rats by transfer of peritoneal mononuclear cells from rats injected with semisoluble aminated glucan.
    Almdahl SM; Bøgwald J; Hoffman J; Seljelid R
    Acta Chir Scand; 1987 Sep; 153(9):535-9. PubMed ID: 3321808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-glucan, extracted from oat, enhances disease resistance against bacterial and parasitic infections.
    Yun CH; Estrada A; Van Kessel A; Park BC; Laarveld B
    FEMS Immunol Med Microbiol; 2003 Jan; 35(1):67-75. PubMed ID: 12589959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased resistance to Staphylococcus aureus infection and enhancement in serum lysozyme activity by glucan.
    Kokoshis PL; Williams DL; Cook JA; Di Luzio NR
    Science; 1978 Mar; 199(4335):1340-2. PubMed ID: 628841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of pulmonary phagocytes in host defense against group B streptococci in preterm versus term rabbit lung.
    Sherman MP; Johnson JT; Rothlein R; Hughes BJ; Smith CW; Anderson DC
    J Infect Dis; 1992 Oct; 166(4):818-26. PubMed ID: 1527417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experimental study of nonspecific protective reactions during infection with conditionally pathogenic bacteria].
    Oleĭnikova EA; Rozenberg VD; Kozhevnikova VM; Kiseleva RE
    Biull Eksp Biol Med; 1973 Oct; 75(10):80-2. PubMed ID: 4592092
    [No Abstract]   [Full Text] [Related]  

  • 32. Glucan induced modification of experimental Staphylococcus aureus infection in normal, leukemic and immunosuppressed mice.
    Williams DL; Di Luzio NR
    Adv Exp Med Biol; 1979; 121(A):291-306. PubMed ID: 547728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of pulmonary edema on antibacterial defenses of the lung.
    LaForce FM; Mullane JF; Boehme RF; Kelly WJ; Huber GL
    J Lab Clin Med; 1973 Oct; 82(4):634-48. PubMed ID: 4755437
    [No Abstract]   [Full Text] [Related]  

  • 34. Aminophylline-induced suppression of pulmonary antibacterial defenses.
    Nelson S; Summer WR; Jakab GJ
    Am Rev Respir Dis; 1985 Jun; 131(6):923-7. PubMed ID: 3890643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variations in lung water and pulmonary host defense mechanisms.
    Mullane JF; La Force FM; Huber GL
    Am Surg; 1973 Nov; 39(11):630-6. PubMed ID: 4800366
    [No Abstract]   [Full Text] [Related]  

  • 36. Erythromycin-induced suppression of pulmonary antibacterial defenses. A potential mechanism of superinfection in the lung.
    Nelson S; Summer WR; Terry PB; Warr GA; Jakab GJ
    Am Rev Respir Dis; 1987 Nov; 136(5):1207-12. PubMed ID: 3314615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of post-operative C. albicans sepsis by glucan immunostimulation.
    Browder IW; Williams DL; Kitahama A; Di Luzio NR
    Int J Immunopharmacol; 1984; 6(1):19-26. PubMed ID: 6724765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA-induced intensification of antibacterial resistance and aggravation of infection.
    Zemskov VM
    J Hyg Epidemiol Microbiol Immunol; 1977; 21(2):195-202. PubMed ID: 562374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung antibacterial defense mechanisms in infant and adult rats: implications for the pathogenesis of group B streptococcal infections in the neonatal lung.
    Martin TR; Rubens CE; Wilson CB
    J Infect Dis; 1988 Jan; 157(1):91-100. PubMed ID: 3275727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uptake of bloodborne bacteria by pulmonary intravascular macrophages and consequent inflammatory responses in sheep.
    Warner AE; Molina RM; Brain JD
    Am Rev Respir Dis; 1987 Sep; 136(3):683-90. PubMed ID: 3631739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.